• Title of article

    Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study

  • Author/Authors

    Peter M. Okin، نويسنده , , Richard B. Devereux، نويسنده , , Markku S. Nieminen، نويسنده , , Sverker Jern، نويسنده , , Lasse Oikarinen، نويسنده , , Matti Viitasalo، نويسنده , , Lauri Toivonen، نويسنده , , Sverre E. Kjeldsen، نويسنده , , Stevo Julius، نويسنده , , Bjorn Dahlof، نويسنده , , for the LIFE Study Investigators، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2001
  • Pages
    7
  • From page
    514
  • To page
    520
  • Abstract
    OBJECTIVES This study was designed to assess the relation of electrocardiographic (ECG) strain to increased left ventricular (LV) mass, independent of its relation to coronary heart disease (CHD). BACKGROUND The classic ECG strain pattern, ST depression and T-wave inversion, is a marker for left ventricular hypertrophy (LVH) and adverse prognosis. However, the independence of the relation of strain to increased LV mass from its relation to CHD has not been extensively examined. METHODS Electrocardiograms and echocardiograms were examined at study baseline in 886 hypertensive patients with ECG LVH by Cornell voltage-duration product and/or Sokolow-Lyon voltage enrolled in the Losartan Intervention For End point (LIFE) echocardiographic substudy. Strain was defined as a downsloping convex ST segment with inverted asymmetrical T-wave opposite to the QRS axis in leads V5 and/or V6. RESULTS Strain occurred in 15% of patients, more commonly in patients with than without evident CHD (29%, 51/175 vs. 11%, 81/711, p < 0.001). When differences in gender, race, diabetes, systolic pressure, serum creatinine and high density lipoprotein cholesterol were controlled, strain on baseline ECG was associated with greater indexed LV mass in patients with (152 ± 33 vs. 131 ± 32 g/m2, p < 0.001) or without CHD (131 ± 24 vs. 119 ± 22 g/m2, p < 0.001). In logistic regression analyses, strain was associated with an increased risk of anatomic LVH in patients with CHD (relative risk 5.14, 95% confidence interval [CI] 1.16 to 22.85, P = 0.0315), without evident CHD (relative risk 2.91, 95% CI 1.50 to 5.65, P = 0.0016), and in the overall population when CHD was taken into account (relative risk 2.98, 95% CI 1.65 to 5.38, P = 0.0003). CONCLUSIONS When clinical evidence of CHD is accounted for, ECG strain is likely to indicate the presence of anatomic LVH. Greater LV mass and higher prevalence of LVH in patients with strain offer insights into the known association of the strain pattern with adverse outcomes.
  • Keywords
    high density lipoprotein , Losartan Intervention For End point study , Life , LV , Left ventricular , LVH , ASE , Left ventricular hypertrophy , American Society of Echocardiography , CHD , coronary heart disease , Electrocardiogram , electrocardiographic , end-systolic stress , ESS , HDL , ECG
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    2001
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    596742